集体诉讼通知概要 - Gross Law Firm向agilon health, inc (NYSE: AGL)的股东发布集体诉讼通知 鼓励在特定集体诉讼期间购买股票的股东联系该律所 以探讨可能的首席原告任命事宜 但参与索赔无需担任首席原告 [1] 诉讼指控内容 - 集体诉讼期间为2025年2月26日至2025年8月4日 [3] - 指控被告在集体诉讼期间发布了重大虚假和/或误导性陈述 和/或未能披露以下信息 [3] - 指控具体内容包括 被告鲁莽地发布了其知道或理应知道无法实现的2025年业绩指引 因为他们知晓重大的行业不利因素 [3] - 指控具体内容包括 被告在材料层面夸大了agilon为降低风险所采取的“战略行动”能带来的即时积极财务影响 [3] - 指控具体内容包括 因此 被告关于agilon业务、运营和前景的陈述在所有相关时间点均存在重大虚假和误导性 和/或缺乏合理依据 [3] 后续步骤与截止日期 - 股东参与集体诉讼的登记截止日期为2026年3月2日 [4] - 股东登记后将被纳入案件组合监控软件 以便在整个案件生命周期内获取状态更新 [4] - 寻求成为首席原告的截止日期为2026年3月2日 [4] - 参与本案对股东无任何成本或义务 [4]

公司事件与股价影响 - 公司首席执行官、总裁兼董事Steven Sell于2025年8月4日立即卸任 同时公司撤回了其2025年全年财务指引[2] - 公司股价在2025年8月4日盘后交易中下跌超过25%[2] - 公司将此变动归因于意外的医疗成本压力和先前收入预估的下调[2] 诉讼指控内容 - 指控公司在整个集体诉讼期间 在明知或应知存在重大行业阻力的情况下 鲁莽地发布了其知道或应该知道无法实现的2025年指引[3] - 指控公司严重夸大了其为降低风险所采取的战略行动所带来的即时积极财务影响[3] - 指控结果导致公司关于其业务、运营和前景的陈述在所有时间点都存在重大虚假和/或误导性[3] 诉讼相关方与时间 - 诉讼针对agilon health公司及其部分高管提起[1] - 有资格参与集体诉讼的投资者可能包括在2025年2月26日至2025年8月4日期间购买公司普通股并遭受股价下跌的投资者[4] - 寻求被任命为首席原告的截止日期是2026年3月2日[5]

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired Agilon securities between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- What’s Happening? Braga ...

On this news, agilon's stock price fell $0.93, or 51.5%, to close at $0.88 per share on August 5, 2025, thereby injuring investors. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Defendants recklessly issued g ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIR ...

NEW YORK, Jan. 14, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 4, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/agilo ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in agilon health to Contact Him Directly to Discuss Their OptionsIf you purchased or acquired securities in agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - Ja ...

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Agilon and certain of its offic ...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased agilon health, inc. ("agilon†or the "Company†) (NYSE: AGL) securities between February 26, 2025 and August 4, 2025, inclusive (the "Class Period†). agilon investors have until March 2, 2026 to file a lead plaintiff motion. On this news, agilon's stock price fell $0.93, or 51.5%, to close at $0.88 per share on August 5, 2025, thereby injuring investor ...

诉讼概述 - 律师事务所Kirby McInerney LLP宣布，已代表在2025年2月26日至2025年8月2日期间（含）购买了agilon health, inc. (NYSE:AGL) 证券的投资者提起集体诉讼 [1] - 诉讼指控公司作出了虚假和/或误导性陈述，和/或未能披露：(1) 在明知或应知存在重大行业阻力的情况下，公司仍轻率地发布了其知道或应该知道无法实现的2025年业绩指引；(2) 公司严重夸大了其为降低风险所采取的“战略行动”能带来的即时积极财务影响 [1] 公司事件与股价影响 - 2025年8月4日，公司发布新闻稿宣布领导层变动，总裁、首席执行官兼董事会董事Steven Sell已卸任，其离职被定性为雇佣协议下的“无因”终止 [2] - 同日，公司发布2025年第二季度业绩，执行主席评论称“在我们推进这个过渡年时，情况变得清晰，行业阻力比此前预期的更为严峻”，并宣布“暂停此前发布的2025年全年财务指引及相关假设” [2] - 受此消息影响，agilon股价从2025年8月4日的每股1.82美元下跌0.94美元，跌幅约51.6%，于2025年8月5日收于每股0.88美元 [2] 行业与公司运营状况 - 公司承认，在2025年这个过渡年，行业阻力变得比之前预期的更为严峻 [2] - 公司因行业阻力超出预期而暂停了其2025年全年财务指引 [2]